Literature DB >> 20473614

Time to rheology in acute myocardial infarction: inflammation and erythrocyte aggregation as a consequence and not necessarily as precursors of the disease.

Arie Steinvil1, Shlomo Berliner, Itzhak Shapira, Ori Rogowski, Dan Justo, Jacob George, Amir Halkin, Gad Keren, Ariel Finkelstein, Shmuel Banai, Yaron Arbel.   

Abstract

BACKGROUND: Previous studies have demonstrated the presence of increased erythrocyte aggregation (EA) in patients with acute coronary syndromes (ACS). We have presently explored the correlation between the time from symptom onset to the appearance of an inflammatory response and aggregated erythrocytes in the peripheral blood of ACS patients.
METHODS: Consecutive individuals undergoing coronary catheterization at the Tel-Aviv Souraski medical center were enrolled. Matched controls were fitted for each case in order to compare the EA and inflammatory response in each time quartile from symptom onset. Linear regression models were fitted for wide-range C-reactive protein (wr-CRP), fibrinogen and for the Vacuum R a measure of EA, as the dependant variables and adjusted to multiple cardiovascular risk factors, relevant medications as well as to time from symptom onset to angiography.
RESULTS: The study population comprised 428 male patients, 223 with unstable angina and 205 with acute myocardial infarction (AMI). A significant time-dependant increase in the concentrations of inflammation-sensitive biomarkers as well as EA has been noted only in the AMI group. Time from onset of pain to angiography entered as a significant predictor of fibrinogen, wr-CRP, and VR (r (2) = 0.24, p < 0.001; r (2) = 0.18, p < 0.001; r (2) = 0.6, p = 0.04; respectively).
CONCLUSION: The results indicate that erythrocyte aggregation and inflammation increase as time from clinical symptom onset lengthens during the course of AMI.

Entities:  

Mesh:

Year:  2010        PMID: 20473614     DOI: 10.1007/s00392-010-0167-1

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  30 in total

1.  Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update.

Authors:  G Maresca; A Di Blasio; R Marchioli; G Di Minno
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-06       Impact factor: 8.311

2.  Relationship between erythrocyte aggregate size and flow rate in skeletal muscle venules.

Authors:  Jeffrey J Bishop; Patricia R Nance; Aleksander S Popel; Marcos Intaglietta; Paul C Johnson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-09-11       Impact factor: 4.733

3.  Elevated plasma fibrinogen level predicts suboptimal response to therapy with both single- and double-bolus eptifibatide during percutaneous coronary intervention.

Authors:  Ehtisham Mahmud; Jeffrey J Cavendish; Sotirios Tsimikas; Lawrence Ang; Cuong Nguyen; Guilherme Bromberg-Marin; Guido Schnyder; Shahin Keramati; Vachaspathi Palakodeti; William F Penny; Anthony N DeMaria
Journal:  J Am Coll Cardiol       Date:  2007-05-18       Impact factor: 24.094

4.  Effect of erythrocyte aggregation at normal human levels on functional capillary density in rat spinotrapezius muscle.

Authors:  Sangho Kim; Aleksander S Popel; Marcos Intaglietta; Paul C Johnson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-09-23       Impact factor: 4.733

5.  Involvement of erythrocyte aggregation and erythrocyte resistance to flow in acute coronary syndromes.

Authors:  C Pfafferott; G Moessmer; A M Ehrly; R M Bauersachs
Journal:  Clin Hemorheol Microcirc       Date:  1999       Impact factor: 2.375

6.  Haemorheological pattern in young adults with acute myocardial infarction.

Authors:  G Caimi; E Hoffmann; M Montana; B Canino; F Dispensa; A Catania; R Lo Presti
Journal:  Clin Hemorheol Microcirc       Date:  2003       Impact factor: 2.375

7.  Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.

Authors:  Pierluigi Tricoci; Yuliya Lokhnygina; Lisa G Berdan; Steven R Steinhubl; Dietrich C Gulba; Harvey D White; Neal S Kleiman; Philip E Aylward; Anatoly Langer; Robert M Califf; James J Ferguson; Elliott M Antman; L Kristin Newby; Robert A Harrington; Shaun G Goodman; Kenneth W Mahaffey
Journal:  Circulation       Date:  2007-11-19       Impact factor: 29.690

8.  Thrombolytic therapy reduces red blood cell aggregation in plasma without affecting intrinsic aggregability.

Authors:  R Ben-Ami; G Sheinman; S Yedgar; A Eldor; A Roth; A S Berliner; G Barshtein
Journal:  Thromb Res       Date:  2002-03-15       Impact factor: 3.944

9.  Significant dominance of fibrinogen over immunoglobulins, C-reactive protein, cholesterol and triglycerides in maintaining increased red blood cell adhesiveness/aggregation in the peripheral venous blood: a model in hypercholesterolaemic patients.

Authors:  V Schechner; I Shapira; S Berliner; D Comaneshter; T Hershcovici; J Orlin; D Zeltser; M Rozenblat; K Lachmi; M Hirsch; Y Beigel
Journal:  Eur J Clin Invest       Date:  2003-11       Impact factor: 4.686

10.  Haemorheological parameters in young patients with acute myocardial infarction.

Authors:  Esther Zorio; Julián Murado; David Arizo; Joaquín Rueda; Dolores Corella; María Simó; Amparo Vayá
Journal:  Clin Hemorheol Microcirc       Date:  2008       Impact factor: 2.375

View more
  4 in total

1.  Admission C-reactive protein and short- as well as long-term mortality in diabetic versus non-diabetic patients with incident myocardial infarction.

Authors:  C Meisinger; M Heier; W von Scheidt; B Kuch
Journal:  Clin Res Cardiol       Date:  2010-07-02       Impact factor: 5.460

2.  Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock.

Authors:  Roland Prondzinsky; Susanne Unverzagt; Henning Lemm; Nikolas-Arne Wegener; Axel Schlitt; Konstantin M Heinroth; Sebastian Dietz; Ute Buerke; Patrick Kellner; Harald Loppnow; Martin G Fiedler; Joachim Thiery; Karl Werdan; Michael Buerke
Journal:  Clin Res Cardiol       Date:  2012-01-03       Impact factor: 5.460

3.  Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation.

Authors:  Bernhard Richter; Marianne Gwechenberger; Ariel Socas; Gerlinde Zorn; Sulaima Albinni; Manfred Marx; Jutta Bergler-Klein; Thomas Binder; Johann Wojta; Heinz D Gössinger
Journal:  Clin Res Cardiol       Date:  2011-11-19       Impact factor: 5.460

4.  Diagnostic Ultrasound and Microbubbles Treatment Improves Outcomes of Coronary No-Reflow in Canine Models by Sonothrombolysis.

Authors:  Hairui Li; Yongkang Lu; Yili Sun; Gangbin Chen; Junfen Wang; Shifei Wang; Chixiong Huang; Lintao Zhong; Xiaoyun Si; Wangjun Liao; Yulin Liao; Shiping Cao; Jianping Bin
Journal:  Crit Care Med       Date:  2018-09       Impact factor: 7.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.